| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 42.32B | 42.75B | 42.84B | 42.80B | 37.84B | 36.24B |
| Gross Profit | 5.32B | 4.41B | 5.80B | 5.61B | 4.65B | 5.14B |
| EBITDA | 3.60B | 3.83B | 3.78B | 3.79B | 3.16B | 3.58B |
| Net Income | 671.18M | 843.51M | 1.01B | 1.21B | 592.00M | 1.51B |
Balance Sheet | ||||||
| Total Assets | 31.68B | 31.36B | 31.04B | 32.26B | 27.79B | 29.09B |
| Cash, Cash Equivalents and Short-Term Investments | 1.63B | 1.61B | 1.25B | 1.20B | 1.23B | 2.95B |
| Total Debt | 6.70B | 8.32B | 7.07B | 7.22B | 5.07B | 5.67B |
| Total Liabilities | 19.40B | 18.54B | 19.10B | 19.98B | 16.45B | 16.86B |
| Stockholders Equity | 11.92B | 12.47B | 11.52B | 11.88B | 10.94B | 11.84B |
Cash Flow | ||||||
| Free Cash Flow | 2.79B | 1.82B | 1.46B | 601.00M | 414.00M | 1.57B |
| Operating Cash Flow | 4.22B | 3.66B | 3.63B | 3.15B | 2.10B | 2.94B |
| Investing Cash Flow | -1.58B | -1.73B | -2.59B | -4.50B | -2.04B | -2.28B |
| Financing Cash Flow | -2.08B | -1.56B | -989.00M | 1.34B | -1.73B | -1.11B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | C$5.70B | 5.79 | 10.37% | 1.32% | 2.38% | 149.43% | |
71 Outperform | C$23.15B | -328.99 | 5.42% | 3.69% | 0.29% | -40.45% | |
70 Outperform | C$14.95B | 18.41 | 14.41% | 1.44% | 4.34% | -4.98% | |
69 Neutral | C$281.98M | 12.39 | 6.05% | 6.21% | -2.28% | -7.56% | |
69 Neutral | C$746.73M | 6.02 | 7.74% | 1.93% | -1.63% | ― | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
46 Neutral | C$497.04M | 24.24 | 3.40% | ― | -6.30% | ― |